The effect of hyperbaric oxygen therapy on the adverse effects of octreotide on wound healing

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 5, 2004, Pages 475-478

  Yildiz, Senol ^a   Uluutku, Haldun ^a   Gunay, Alp ^a   Yildirim, Ismail ^a   Yildirim, Şukru ^a   Gurbuz, Ahmet Kemal ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Hyperbaric oxygen treatment; Octreotide; Wound healing

Indexed keywords

HYDROXYPROLINE; OCTREOTIDE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; FIBROSIS; HYPERBARIC OXYGEN; MALE; NONHUMAN; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RAT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WOUND HEALING;

ANIMALS; HYPERBARIC OXYGENATION; MALE; OCTREOTIDE; RANDOM ALLOCATION; RATS; RATS, WISTAR; VASOCONSTRICTOR AGENTS; WOUND HEALING;

EID: 2342564407     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200405000-00007     Document Type: Article

References (35)

1. Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D'Heygere F, McIntrye N. Randomised, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990; 99:1388-1395.
2. Gullo L, Barbara L. Treatment of pancreatic pseudocysts with octreotide. Lancet 1991; 338:540-541.
3. Mozell EJ, Woltering EA, O'Dorisio TM. Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy. Dis Month 1991; 37:751-848.
4. Evers BM, Parekh D, Townsend CM, Tompson JC. Somatostatin and analogues in the treatment of cancer. Ann Surg 1991; 213:190-198.
5. Bass BL, Fischer BA, Richardson C, Harmon JW. Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats. Am J Surg 1991; 161:107-112.
6. Pruthi RS, Farouk M, Tsai WH, Michalopoulos G, Meyers WC. The effect of octreotide on hepatic regeneration in rats. Surgery 1993; 113:84-89.
7. Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988; 94:1300-1307.
8. Lavan FB, Hunt TK. Oxygen and wound healing. Clin Plast Surg 1990; 17:463-472.
9. Jain KK. Physical, physiological, and biochemical aspects of hyperbaric oxygenation. In: Jain KK, Neubauer R, Correa JG, Camporesi EM (eds): Textbook of Hyperbaric Medicine. Seattle: Hogrefe & Huber; 1996, pp. 11-26.
10. Oriani G, Michael M, Marroni A, Longoni C. Physiology and physiopathology of hyperbaric oxygen. In: Oriani G, Marroni A, Wattel F (eds): Handbook on Hyperbaric Medicine. Milan: Springer-Verlag; 1996, pp. 1-34.
11. Bonomo SR, Davidson JR, Tyrone JW, Lin X, Mustoe TA. Enhancement of wound healing by hyperbaric oxygen and transforming growth factor beta3 in a new chronic wound model in aged rabbits. Arch Surg 2000; 135:1148-1153.
12. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996; 29:225-229.
13. Waddell BE, Calton WC Jr, Steinberg SR, Martindale RG. The adverse effects of octreotide on wound healing in rats. Am Surg 1997; 63: 446-449.
14. Hurst RD, Modlin IM. The therapeutic role of ocreotide in the management of surgical disorders. Am J Surg 1991; 162:499-507.
15. Nubiola P, Badia JM, Martinez-Rodenas F, Gil MJ, Segura M, Sancho J, Sitges-Serra A. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 210-995. Ann Surg 1989; 210:56-58.
16. Rosen GH. Somatostatin and its analogs in the short bowel syndrome. Nutr Clin Pract 1992; 7:81-85.
17. Geer RJ, Richards WO, O'Dorisio TM, Woltering EO, Williams S, Rice D, Abumrad NN. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990; 212:678-687.
18. Gray JL, Debas HT, Mulvihill SJ. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery. Arch Surg 1991; 126:1231-1236.
19. Wu L, Xia YP, Roth SI, Gruskin E, Mustoe TA. Transforming growth factor-beta1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model: importance of oxygen and age. Am J Pathol 1999; 154:301-309.
20. Suh DY, Hunt TK. Time line of wound healing. Clin Pediatr Med Surg 1998; 15:1-9.
21. Ishii Y, Miyanaga Y, Shimojo H, Ushida T, Tateishi T. Effects of hyperbaric oxygen on procollagen messenger RNA levels and collagen synthesis in the healing of rat tendon laceration. Tissue Eng 1999; 5:279-286.
22. Clark LA, Moon RE. Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin North Am 1999; 5:203-219.
23. Mader JT, Brown GL, Guckian JC, Wells CH, Reinarz JA. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 1980; 142:915-922.
24. Meltzer T, Myers B. The effect of hyperbaric oxygen on the bursting strength and rate of vascularization of skin wounds in the rat. Am Surg 1986; 52:659-662.
25. Beckham PH, Hitchcock CR. Effect of hyperbaric oxygenation on wound strength in dogs: a preliminary report. In: Ledingham IM (ed.): Hyperbaric Oxygenation: Proceedings of the Second International Congress. London: E.S. Livingstone; 1965, pp. 397-408.
26. Manson PN, Im MJ, Myers RAM, Hoopes JE. Improved capillaries by hyperbaric oxygen in skin flaps. Surg Forum 1980; 31:564-565.
27. Hartwig J, Kohnlein HE. The influence of hyperbaric oxygen therapy and dextran 40 on wound healing. Eur Surg Res 1973; 5 (suppl):109.
28. Tur E, Bolton L, Constantine BE. Topical hydrogen peroxide treatment of ischemic ulcers in the guinea pig: blood recruitment in multiple skin sites. J Am Acad Dermatol 1995; 33:217-221.
29. Kayanoki Y, Higashiyama S, Suzuki K, Asahi M, Kawata S, Matsuzawa Y, Taniguchi N. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells. Biochem Biophys Res Commun 1999; 259:50-55.
30. Mueller RV, Hunt TK, Tokunaga A, Spencer EM. The effect of insulin-like growth factor I on wound healing variables and macrophages in rats. Arch Surg 1994; 129:262-265.
31. Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S. Oxygen, oxidants, and antioxidants in wound healing. An emerging paradigm. Ann N Y Acad Sci 2002; 997:239-249.
32. Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, et al. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 1996; 318:379-382.
33. Boykin JV. The nitric oxide connection: hyperbaric oxygen therapy, becaplermin, and diabetic ulcer management. Adv Skin Wound Care 2000; 13:169-174.
34. Hamon GA, Hunt TK, Spencer EM. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul 1993; 3:53-56.
35. Suh DY, Hunt TK, Spencer EM. Insulin-like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology 1992; 131:2399-2403.